SGP
SGP clinical trials: SpyGlass Pharma, Inc.
Every trial on ClinicalTrials.gov where SpyGlass Pharma, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 6
- Trials linked
- 6
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
SGP on the catalyst calendar · SGP registry changes
- Primary completion Feb 28, 2027Sponsor estimatePhase 1NCT07641296Evaluation of the Safety, Efficacy, Dose Response of the Bimatoprost Drug Ring System (BIM-DRS) in Pseudophakic Patients Diagnosed With...SpyGlass Pharma, Inc. · GlaucomaNot yet recruitingSGPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 31, 2029Sponsor estimatePhase 3NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol...SpyGlass Pharma, Inc. · CataractRecruitingSGPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2029Sponsor estimatePhase 3NCT07218783Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol...SpyGlass Pharma, Inc. · CataractRecruitingSGPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 14, 2031Sponsor estimateNo phase registeredNCT07154810Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost...SpyGlass Pharma, Inc. · GlaucomaActive, not recruitingSGPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 13, 2022ActualNo phase registeredNCT07154797Evaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or...SpyGlass Pharma, Inc. · CataractCompletedSGPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2025ActualPhase 1/Phase 2NCT06120842Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic SolutionSpyGlass Pharma, Inc. · CataractActive, not recruitingSGPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 6 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner